Literature DB >> 10780940

Effect of dexamethasone on fetal hepatic glutamine-glutamate exchange.

M Timmerman1, C Teng, R B Wilkening, P Fennessey, F C Battaglia, G Meschia.   

Abstract

Intravenous infusion of dexamethasone (Dex) in the fetal lamb causes a two- to threefold increase in plasma glutamine and other glucogenic amino acids and a decrease of plasma glutamate to approximately one-third of normal. To explore the underlying mechanisms, hepatic amino acid uptake and conversion of L-[1-(13)C]glutamine to L-[1-(13)C]glutamate and (13)CO(2) were measured in six sheep fetuses before and in the last 2 h of a 26-h Dex infusion. Dex decreased hepatic glutamine and alanine uptakes (P < 0.01) and hepatic glutamate output (P < 0.001). Hepatic outputs of the glutamate (R(Glu,Gln)) and CO(2) formed from plasma glutamine decreased to 21 (P < 0.001) and 53% (P = 0.009) of control, respectively. R(Glu,Gln), expressed as a fraction of both outputs, decreased (P < 0.001) from 0.36 +/- 0.02 to 0.18 +/- 0.04. Hepatic glucose output remained virtually zero throughout the experiment. We conclude that Dex decreases fetal hepatic glutamate output by increasing the routing of glutamate carbon into the citric acid cycle and by decreasing the hepatic uptake of glucogenic amino acids.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10780940     DOI: 10.1152/ajpendo.2000.278.5.E839

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  9 in total

1.  Sustained hypoxemia in late gestation potentiates hepatic gluconeogenic gene expression but does not activate glucose production in the ovine fetus.

Authors:  Amanda K Jones; Paul J Rozance; Laura D Brown; David A Goldstrohm; William W Hay; Sean W Limesand; Stephanie R Wesolowski
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-04-09       Impact factor: 4.310

Review 2.  Placental efficiency and adaptation: endocrine regulation.

Authors:  A L Fowden; A N Sferruzzi-Perri; P M Coan; M Constancia; G J Burton
Journal:  J Physiol       Date:  2009-05-18       Impact factor: 5.182

3.  Coordinated changes in hepatic amino acid metabolism and endocrine signals support hepatic glucose production during fetal hypoglycemia.

Authors:  Satya S Houin; Paul J Rozance; Laura D Brown; William W Hay; Randall B Wilkening; Stephanie R Thorn
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-12-16       Impact factor: 4.310

4.  Role of placental insufficiency and intrauterine growth restriction on the activation of fetal hepatic glucose production.

Authors:  Stephanie R Wesolowski; William W Hay
Journal:  Mol Cell Endocrinol       Date:  2015-12-23       Impact factor: 4.102

Review 5.  Transport and metabolism of amino acids in placenta.

Authors:  Timothy R H Regnault; Barbra de Vrijer; Frederick C Battaglia
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

6.  Exogenous amino acids suppress glucose oxidation and potentiate hepatic glucose production in late gestation fetal sheep.

Authors:  Laura D Brown; Jaden R Kohn; Paul J Rozance; William W Hay; Stephanie R Wesolowski
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-02-08       Impact factor: 3.619

7.  Fetal Sex Does Not Impact Placental Blood Flow or Placental Amino Acid Transfer in Late Gestation Pregnant Sheep With or Without Placental Insufficiency.

Authors:  Laura D Brown; Claire Palmer; Lucas Teynor; Brit H Boehmer; Jane Stremming; Eileen I Chang; Alicia White; Amanda K Jones; Sarah N Cilvik; Stephanie R Wesolowski; Paul J Rozance
Journal:  Reprod Sci       Date:  2021-10-05       Impact factor: 2.924

Review 8.  Metabolic Consequences of Glucocorticoid Exposure before Birth.

Authors:  Abigail L Fowden; Owen R Vaughan; Andrew J Murray; Alison J Forhead
Journal:  Nutrients       Date:  2022-05-30       Impact factor: 6.706

Review 9.  Programming placental nutrient transport capacity.

Authors:  A L Fowden; J W Ward; F P B Wooding; A J Forhead; M Constancia
Journal:  J Physiol       Date:  2006-01-26       Impact factor: 5.182

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.